ES2552521T3 - Infusión intravenosa de ibuprofeno - Google Patents

Infusión intravenosa de ibuprofeno Download PDF

Info

Publication number
ES2552521T3
ES2552521T3 ES13000827.9T ES13000827T ES2552521T3 ES 2552521 T3 ES2552521 T3 ES 2552521T3 ES 13000827 T ES13000827 T ES 13000827T ES 2552521 T3 ES2552521 T3 ES 2552521T3
Authority
ES
Spain
Prior art keywords
infusion
ibuprofen
intravenous ibuprofen
arginine
intravenous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13000827.9T
Other languages
English (en)
Inventor
Khalil A.H. Selmi
Irfan J. M. Jamil
Yahya H.A. Idris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHARMACEUTICAL SOLUTIONS INDUSTRY Ltd
Original Assignee
PHARMACEUTICAL SOLUTIONS INDUSTRY Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHARMACEUTICAL SOLUTIONS INDUSTRY Ltd filed Critical PHARMACEUTICAL SOLUTIONS INDUSTRY Ltd
Application granted granted Critical
Publication of ES2552521T3 publication Critical patent/ES2552521T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composición farmacéutica que comprende 4 mg/ml de ibuprofeno en una solución acuosa, tampón Tris y arginina, siendo la relación molar entre arginina e ibuprofeno más que o igual a 1,000625:1, siendo dicha composición isotónica con el fluido corporal, tamponada a pH fisiológico de 7,2 a 8,5 y estando lista para usar como una infusión intravenosa.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES13000827.9T 2012-02-20 2013-02-19 Infusión intravenosa de ibuprofeno Active ES2552521T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GCL201220561 2012-02-20
GCL201220561 2012-02-20

Publications (1)

Publication Number Publication Date
ES2552521T3 true ES2552521T3 (es) 2015-11-30

Family

ID=47747319

Family Applications (1)

Application Number Title Priority Date Filing Date
ES13000827.9T Active ES2552521T3 (es) 2012-02-20 2013-02-19 Infusión intravenosa de ibuprofeno

Country Status (12)

Country Link
US (1) US9351926B2 (es)
EP (1) EP2636406B1 (es)
CY (1) CY1117056T1 (es)
DK (1) DK2636406T3 (es)
ES (1) ES2552521T3 (es)
HR (1) HRP20151129T1 (es)
HU (1) HUE028045T2 (es)
PL (1) PL2636406T3 (es)
PT (1) PT2636406E (es)
RS (1) RS54362B1 (es)
SI (1) SI2636406T1 (es)
SM (1) SMT201500278B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103990054A (zh) * 2014-05-28 2014-08-20 孙刚 一种治疗强直性脊柱炎的中药药膏及其制备方法
CN109843266B (zh) * 2016-08-02 2023-08-11 安巴知识产权有限公司 稳定的布洛芬注射组合物
FI3996699T3 (fi) 2019-07-09 2023-08-01 Farmalider Sa Ibuprofeenin ja tramadolin yhdistelmä kivun lievitykseen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040132823A1 (en) * 2001-11-02 2004-07-08 Leo Pavliv Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen

Also Published As

Publication number Publication date
SMT201500278B (it) 2016-01-08
US9351926B2 (en) 2016-05-31
HRP20151129T1 (hr) 2015-12-18
HUE028045T2 (en) 2016-11-28
DK2636406T3 (en) 2015-11-23
CY1117056T1 (el) 2017-04-05
PL2636406T3 (pl) 2016-01-29
EP2636406A1 (en) 2013-09-11
RS54362B1 (sr) 2016-04-28
EP2636406B1 (en) 2015-08-12
SI2636406T1 (sl) 2016-01-29
US20130217772A1 (en) 2013-08-22
PT2636406E (pt) 2015-11-20

Similar Documents

Publication Publication Date Title
AR122746A2 (es) Una formulación farmacéutica líquida estable de anticuerpo
AR098168A1 (es) Formulación estable de insulina glulisina
DOP2012000261A (es) Formulaciones de insulina de accion prolongada
BR112016010103A8 (pt) métodos, kits e dispositivos de suprimento de fármaco osmótico.
AR083344A1 (es) Disposicion para acoplar un embolo ya sea a una jeringa o a un tapon
CL2016001447A1 (es) Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal.
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
CL2013001602A1 (es) Metodo para reducir o inhibir la progresion del nivel de fatiga en pacientes con esclerosis multiple y para proporcionarles neuroproteccion que comprende administrar oralmente laquinimod o una sal del mismo; laquinimod para reducir el nivel de fatiga, mejorar el estado funcional y entregar neuroproteccion en esclerosis multiple.
CL2013003095A1 (es) Un receptaculo de descarga de una cantidad fija, comprende un cilindro de jeringa y un piston, donde uno de ellos incluye una guia que se extiende en una direccion longitudinal y el otro una guia de desplazamiento, donde la guia esta provista de una parte que hace contacto con la posición objetivo, con la que la guia de desplazamiento hace contacto cuando una posicion de la camara de fluido iguala a una cantidad a administrar.
AR093115A1 (es) Soluciones midriaticas y antiinflamatorias inyectables, estables y libres de conservantes
AR098709A1 (es) Válvula de retención
AR087693A1 (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
BR112013016770A2 (pt) formulação farmacêutica, fármaco biofarmacêutico, seringa ou caneta pré-preenchida, uso de uma formulação farmacêutica
MX345256B (es) Formulaciones estables para inyeccion parenteral de farmacos de molecula pequeña.
AR096773A1 (es) Formulación líquida estable
BR112015011946A2 (pt) dispositivo de conexão
CL2017001483A1 (es) Formulación de relación fija de insulina glargina/lixisenatida
AR053803A1 (es) Uso de acido pinolenico
CL2012003488A1 (es) Formulación intravenosa que comprende una solución acuosa de sulfobutil-eter-beta-ciclodextrina y amiodarona o una sal en proporción entre 2,7: 1 a 7:1; metodo de preparación; un artículo manufacturado, util en arritmias.
AR092151A1 (es) Preparacion farmaceutica solida que contiene levotiroxina
ES2552521T3 (es) Infusión intravenosa de ibuprofeno
ES2660019T3 (es) Parche que contiene diclofenaco y tiocolchicósido
AR083380A1 (es) Mecanismo de establecimiento de dosis y metodo para utilizar el mismo
NI201000173A (es) Uso de dronedarona o una sal aceptable farmacéuticamente de ésta, para la preparación de un medicamento para regular el nivel de potasio en la sangre.
PE20141189A1 (es) Preparacion de liberacion sostenida